4A9I - Sequence, Chains, Asymmetric and Biological Units

• Title: N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-METHYL-1,2,3,4- TETRAHYDROQUINAZOLIN-2-ONE
• Keywords: INHIBITOR, HISTONE, EPIGENETIC READER, SIGNALING PROTEIN
• Experiment: X-ray diffraction
• Number of Models: 1

Database	ID code	Status	Coordinate files
			Header	Asymmetric unit	Biological unit
PDB	4A9I	released	available	available	Quaternary Structure Server

Asymmetric unit from PDB

Unit	Type	Name	Chain ID	Residues	Atoms	Hetatoms
1	Protein	BROMODOMAIN CONTAINING 2	A	110	920	0
2	Protein	BROMODOMAIN CONTAINING 2	B	116	955	0
3	Protein	BROMODOMAIN CONTAINING 2	C	107	891	0
4	Ligand	BROMODOMAIN CONTAINING 2	A	3	0	28
5	Ligand	BROMODOMAIN CONTAINING 2	B	2	0	22
6	Ligand	BROMODOMAIN CONTAINING 2	C	2	0	23
7	Water			233	0	233
total				573	2766	306

Proteins

Unit 1	VAL 75 THR 76 ASN 77 GLN 78 LEU 79 GLN 80 TYR 81 LEU 82 HIS 83 LYS 84 VAL 85 VAL 86 MET 87 LYS 88 ALA 89 LEU 90 TRP 91 LYS 92 HIS 93 GLN 94 PHE 95 ALA 96 TRP 97 PRO 98 PHE 99 ARG 100 GLN 101 PRO 102 VAL 103 ASP 104 ALA 105 VAL 106 LYS 107 LEU 108 GLY 109 LEU 110 PRO 111 ASP 112 TYR 113 HIS 114 LYS 115 ILE 116 ILE 117 LYS 118 GLN 119 PRO 120 MET 121 ASP 122 MET 123 GLY 124 THR 125 ILE 126 LYS 127 ARG 128 ARG 129 LEU 130 GLU 131 ASN 132 ASN 133 TYR 134 TYR 135 TRP 136 ALA 137 ALA 138 SER 139 GLU 140 CYS 141 MET 142 GLN 143 ASP 144 PHE 145 ASN 146 THR 147 MET 148 PHE 149 THR 150 ASN 151 CYS 152 TYR 153 ILE 154 TYR 155 ASN 156 LYS 157 PRO 158 THR 159 ASP 160 ASP 161 ILE 162 VAL 163 LEU 164 MET 165 ALA 166 GLN 167 THR 168 LEU 169 GLU 170 LYS 171 ILE 172 PHE 173 LEU 174 GLN 175 LYS 176 VAL 177 ALA 178 SER 179 MET 180 PRO 181 GLN 182 GLU 183 GLU 184
Unit 2	VAL 60 PRO 72 GLY 73 ARG 74 VAL 75 THR 76 ASN 77 GLN 78 LEU 79 GLN 80 TYR 81 LEU 82 HIS 83 LYS 84 VAL 85 VAL 86 MET 87 LYS 88 ALA 89 LEU 90 TRP 91 LYS 92 HIS 93 GLN 94 PHE 95 ALA 96 TRP 97 PRO 98 PHE 99 ARG 100 GLN 101 PRO 102 VAL 103 ASP 104 ALA 105 VAL 106 LYS 107 LEU 108 GLY 109 LEU 110 PRO 111 ASP 112 TYR 113 HIS 114 LYS 115 ILE 116 ILE 117 LYS 118 GLN 119 PRO 120 MET 121 ASP 122 MET 123 GLY 124 THR 125 ILE 126 LYS 127 ARG 128 ARG 129 LEU 130 GLU 131 ASN 132 ASN 133 TYR 134 TYR 135 TRP 136 ALA 137 ALA 138 SER 139 GLU 140 CYS 141 MET 142 GLN 143 ASP 144 PHE 145 ASN 146 THR 147 MET 148 PHE 149 THR 150 ASN 151 CYS 152 TYR 153 ILE 154 TYR 155 ASN 156 LYS 157 PRO 158 THR 159 ASP 160 ASP 161 ILE 162 VAL 163 LEU 164 MET 165 ALA 166 GLN 167 THR 168 LEU 169 GLU 170 LYS 171 ILE 172 PHE 173 LEU 174 GLN 175 LYS 176 VAL 177 ALA 178 SER 179 MET 180 PRO 181 GLN 182 GLU 183 GLU 184 GLN 185 GLU 186
Unit 3	THR 76 ASN 77 GLN 78 LEU 79 GLN 80 TYR 81 LEU 82 HIS 83 LYS 84 VAL 85 VAL 86 MET 87 LYS 88 ALA 89 LEU 90 TRP 91 LYS 92 HIS 93 GLN 94 PHE 95 ALA 96 TRP 97 PRO 98 PHE 99 ARG 100 GLN 101 PRO 102 VAL 103 ASP 104 ALA 105 VAL 106 LYS 107 LEU 108 GLY 109 LEU 110 PRO 111 ASP 112 TYR 113 HIS 114 LYS 115 ILE 116 ILE 117 LYS 118 GLN 119 PRO 120 MET 121 ASP 122 MET 123 GLY 124 THR 125 ILE 126 LYS 127 ARG 128 ARG 129 LEU 130 GLU 131 ASN 132 ASN 133 TYR 134 TYR 135 TRP 136 ALA 137 ALA 138 SER 139 GLU 140 CYS 141 MET 142 GLN 143 ASP 144 PHE 145 ASN 146 THR 147 MET 148 PHE 149 THR 150 ASN 151 CYS 152 TYR 153 ILE 154 TYR 155 ASN 156 LYS 157 PRO 158 THR 159 ASP 160 ASP 161 ILE 162 VAL 163 LEU 164 MET 165 ALA 166 GLN 167 THR 168 LEU 169 GLU 170 LYS 171 ILE 172 PHE 173 LEU 174 GLN 175 LYS 176 VAL 177 ALA 178 SER 179 MET 180 PRO 181 GLN 182

Ligands

Unit 4	P9I 1185 SO4 1186 SO4 1187
Unit 5	EDO 1187 P9I 1188
Unit 6	P9I 1183 SO4 1184